Date published: 2025-10-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

Crk I Inhibitors

Crk I inhibitors represent a specialized class of compounds targeting the Crk I protein, an adapter protein involved in various signaling pathways that regulate cellular functions such as proliferation, migration, and differentiation. Crk I is a member of the Crk family of proteins, which act as intermediaries that link activated receptors to downstream signaling cascades. By binding to specific phosphorylated tyrosine residues on other proteins, Crk I facilitates the assembly of signaling complexes that promote cellular responses to external stimuli. The modulation of Crk I activity through inhibitors can significantly influence the behavior of cells, making it an important focus for researchers studying cellular signaling mechanisms.

The development of Crk I inhibitors typically involves the identification of small molecules or peptides that can effectively disrupt the interaction between Crk I and its target proteins. These inhibitors are often designed using structure-based approaches, allowing researchers to visualize and predict how these compounds will interact with the Crk I protein. The efficacy of these inhibitors is assessed through a variety of biochemical assays that measure their ability to inhibit Crk I function and downstream signaling events. By exploring the molecular interactions and conformational changes induced by these inhibitors, scientists aim to gain deeper insights into the role of Crk I in cellular processes. As a result, Crk I inhibitors are valuable tools for dissecting complex signaling networks and understanding the functional implications of Crk I in different biological contexts.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$173.00
$418.00
43
(3)

Doxorubicin intercalates into DNA and may downregulate Crk I by blocking the transcriptional elongation process necessary for Crk I mRNA production.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

As a histone deacetylase inhibitor, Trichostatin A could hyperacetylate histones near the CRK gene, leading to a tightened chromatin conformation and decreased Crk I transcription.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This DNA methyltransferase inhibitor can induce hypomethylation of the CRK gene promoter, potentially leading to the silencing of Crk I gene expression.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

This compound binds to the guanine residues of DNA, obstructing RNA polymerase action and could thereby decrease Crk I mRNA synthesis.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin forms a complex with FKBP12 that binds to and inhibits mTOR, leading to inhibited protein synthesis machinery which could include the translation of Crk I mRNA.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD 98059 inhibits MEK1, which could lead to the downregulation of Crk I by inhibiting the ERK pathway and thus reducing the transcriptional activation of the CRK gene.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

As a PI3K inhibitor, LY 294002 could lead to decreased activation of Akt, which in turn may decrease transcriptional factors involved in CRK gene expression, reducing Crk I levels.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

This JNK inhibitor could downregulate Crk I by inhibiting c-Jun N-terminal kinase, potentially decreasing the transcription of genes including CRK.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

U0126 selectively inhibits MEK1/2, possibly leading to reduced ERK pathway signaling and consequent decrease in transcription factors that promote Crk I expression.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB 203580 inhibits p38 MAPK, which could lead to decreased expression of Crk I by reducing the activity of transcription factors that are activated by the p38 MAPK pathway.